biospecimen__admin__batch_number	314.59.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	BC67F309-2EE3-4199-B012-8A27E8D820DB
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-A69I-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-A69I-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BC-A69I-01A
biospecimen__bio__biospecimen_barcode_bottom	0153878280
biospecimen__bio__day_of_creation	07
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	05
biospecimen__bio__month_of_shipment	06
biospecimen__bio__pathology_report_file_name	TCGA-BC-A69I.94F0B317-494A-4467-94A2-5004010E133F.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A310
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-BC-A69I
biospecimen__shared__patient_id	A69I
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	BB24619E-AF8D-408C-BAFC-9A71391D5FB7
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.2
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	13.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150000
clinical__chol_lihc_shared__platelet_result_upper_limit	440000
clinical__chol_lihc_shared__prothrombin_time_result_value	10.4
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	69
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-A69I-F59405
clinical__clin_shared__bcr_followup_uuid	CECFA011-1120-4E2C-B521-CE94CFA191F7
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	18
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	171000
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G1
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	d62a0ef1-2a67-47e7-b468-2a00c25ebab4
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-A69I-01A-11R-A310-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	7da5e556-4868-47e6-b267-ebee7042efd7
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.8
gdc__analytes__analyte_id	e23d4c8f-af49-4924-8034-b97040c64ebd
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	70aecc90-17f0-4064-8ebb-be81f9b1d7fd
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	2b47fbe3-afee-54e0-a10c-bb9a4751072d
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1944
gdc__diagnoses__age_at_diagnosis	25370
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25370.0
gdc__diagnoses__days_to_last_follow_up	387.0
gdc__diagnoses__diagnosis_id	e7f0a05a-da62-58d9-ba7c-17f913bd872f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	29.320987654320987
gdc__exposures__exposure_id	a313a43a-979b-5f8c-9aad-96a458d55211
gdc__exposures__height	180.0
gdc__exposures__weight	95.0
gdc__file_id	9a7a5f6e-5b59-48d4-8ad6-608ddd5e739e
gdc__file_name	8c8e40d1-f62f-4d9d-9435-ef0bc4fcd64e.mirbase21.mirnas.quantification.txt
gdc__file_size	50137
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	86650cd63bbd18211f37d4275f974877
gdc__portions__is_ffpe	false
gdc__portions__portion_id	75c7a4a0-9634-45c7-abeb-72ce48528f68
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	80
gdc__samples__initial_weight	500.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	94F0B317-494A-4467-94A2-5004010E133F
gdc__samples__sample_id	e36d5a75-0bc8-480d-8458-e23cb453c279
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	f195076d-c063-4b17-9693-6e3c2dba1677
gdc__submitter_id	mirna_swap_dr11_234_MirnaExpressionb0f3feeb-6031-42ef-9506-3eaa370981e8_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	4734b508-fc0a-5c51-842b-1a275371b841
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:11:25.881+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d62a0ef1-2a67-47e7-b468-2a00c25ebab4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/d62a0ef1-2a67-47e7-b468-2a00c25ebab4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129508
manually_curated__local_md5	7516ce983a905b33bf428b5734fd5b21
manually_curated__opengdc_download_date	2018-10-16T17:12:48.000952+02:00
manually_curated__opengdc_file_md5	c70d52be57844042e065d88611b97b3a
manually_curated__opengdc_file_size	50136
manually_curated__opengdc_id	d62a0ef1-2a67-47e7-b468-2a00c25ebab4-meq
manually_curated__origin_file_size	129508
manually_curated__origin_last_modified_date	Tue Oct 16 17:41:00 CEST 2018
manually_curated__origin_md5	7516ce983a905b33bf428b5734fd5b21
manually_curated__tissue_status	tumoral
